MCM
BSX icon

Monument Capital Management’s Boston Scientific BSX Stock Holding History

Monument Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,320
Closed -$317K – 223
2025
Q4 		$317K Hold
3,320
– – 0.08% 174
2025
Q3 		$324K Hold
3,320
– – 0.08% 167
2025
Q2 		$357K Sell
3,320
-41
-1% -$4.15K 0.09% 148
2025
Q1 		$339K Buy
3,361
+41
+1% +$4.13K 0.1% 143
2024
Q4 		$297K Buy
3,320
+231
+7% +$20.3K 0.08% 161
2024
Q3 		$259K Sell
3,089
-12
-0.4% -$946 0.07% 167
2024
Q2 		$239K Buy
3,101
+44
+1% +$3.22K 0.07% 155
2024
Q1 		$209K Buy
+3,057
New +$197K 0.06% 183

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Monument Capital Management's BSX Position: Q1 2026 in Review

Monument Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,320 shares — an estimated $317K sold.

Monument Capital Management first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $357K in Q2 2025. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Monument Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Monument Capital Management sold 3,320 Boston Scientific shares in Q1 2026, an estimated $317K.
  • Monument Capital Management first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
  • Monument Capital Management's Boston Scientific position peaked at $357K in Q2 2025.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Monument Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.